Test Price
2,800 AED✅ Home Collection Available
AMT Gene Glycine Encephalopathy Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الحمض النووي لجين AMT لاعتلال الدماغ بالجلايسين في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary (الملخص التنفيذي)
تحليل جين AMT بتقنية التسلسل الجيني من الجيل التالي (NGS) لتشخيص اعتلال الدماغ بالجلايسين (فرط غليسين الدم غير الكيتوني) بدقة تشخيصية تبلغ 99.9%. الخدمة معتمدة من هيئة الصحة بدبي، وتشمل سحب عينة منزلية محترف، واستشارة وراثية ما بعد النتيجة، والتحقق المباشر من التأمين.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview
This advanced Next-Generation Sequencing (NGS) test analyzes the entire coding region of the AMT gene to identify pathogenic variants responsible for glycine encephalopathy (nonketotic hyperglycinemia), enabling accurate diagnosis and family risk stratification. يُحَلِّلُ هذا الفحص الجيني المتقدم جين AMT كاملاً لتشخيص اعتلال الدماغ بالجلايسين وتحديد المخاطر العائلية.
| Feature | Our Test (AMT Gene NGS) | Alternative (Standard Panel) |
|---|---|---|
| Precision | Single-gene full sequencing with 99.9% sensitivity | Multigene panel may miss rare deep-intronic variants |
| Method | Next-Generation Sequencing (NGS) with full bioinformatics | Sanger sequencing of selected exons only |
| Turnaround | 3–4 Weeks | 6–8 Weeks |
Regulatory & Compliance Assurance
This test fully adheres to Federal Decree-Law No. 41 of 2024 (Art. 87) on genetic testing, UAE Personal Data Protection Law (PDPL), and the Child Data Safety (CDS) Law 2026 for minors. Our facility operates under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and DHA license 9834453.
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011) emphasizes: “Every genetic result must be correlated with clinical and biochemical findings. A negative test does not exclude the disorder, and variant interpretation requires expert input. Please discuss your results with your neurologist or genetic counselor.”
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This test is not a substitute for clinical evaluation.
Exclusion Criteria & Emergency Red Flags
- Patients in acute metabolic crisis or with uncontrolled seizures require immediate hospitalization, not elective genetic testing.
- Sudden lethargy, hypotonia, or coma warrants urgent emergency evaluation irrespective of test status.
- Avoid sample collection if the patient is on anticoagulant therapy unless cleared by the supervising physician.
Patient FAQs & Clinical Guidance
1. What is the AMT gene glycine encephalopathy Genetic Test?
This sequences the entire coding region of the AMT gene using Next-Generation Sequencing to detect disease-causing variants for glycine encephalopathy.
2. How is the sample collected and what is the turnaround time?
A blood sample, extracted DNA, or a single drop of blood on an FTA card is collected by our VIP phlebotomy team, and results are ready in 3 to 4 weeks.
3. هل يشمل السعر الاستشارة الوراثية؟
نعم، يشمل السعر استشارة وراثية أولية لرسم شجرة العائلة وتقييم المخاطر، ويُقدِّم فريقنا الإرشاد الوراثي بعد ظهور النتيجة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians